- Home
- SHO vs HRMY Comparison
SHO vs HRMY Comparison
Compare SHO & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHO
- HRMY
- Stock Information
- Founded
- SHO 1995
- HRMY 2017
- Country
- SHO United States
- HRMY United States
- Employees
- SHO N/A
- HRMY N/A
- Industry
- SHO Hotels/Resorts
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- SHO Consumer Discretionary
- HRMY Health Care
- Exchange
- SHO Nasdaq
- HRMY Nasdaq
- Market Cap
- SHO 1.8B
- HRMY 2.0B
- IPO Year
- SHO 1995
- HRMY 2020
- Fundamental
- Price
- SHO $9.41
- HRMY $34.90
- Analyst Decision
- SHO Hold
- HRMY Strong Buy
- Analyst Count
- SHO 7
- HRMY 9
- Target Price
- SHO $9.21
- HRMY $50.56
- AVG Volume (30 Days)
- SHO 1.7M
- HRMY 942.0K
- Earning Date
- SHO 11-07-2025
- HRMY 11-04-2025
- Dividend Yield
- SHO 3.93%
- HRMY N/A
- EPS Growth
- SHO N/A
- HRMY 50.44
- EPS
- SHO 0.01
- HRMY 3.17
- Revenue
- SHO $937,930,000.00
- HRMY $825,944,000.00
- Revenue This Year
- SHO $5.78
- HRMY $20.68
- Revenue Next Year
- SHO $5.62
- HRMY $15.93
- P/E Ratio
- SHO $947.00
- HRMY $11.05
- Revenue Growth
- SHO 3.04
- HRMY 21.13
- 52 Week Low
- SHO $7.45
- HRMY $25.52
- 52 Week High
- SHO $12.41
- HRMY $40.93
- Technical
- Relative Strength Index (RSI)
- SHO 54.00
- HRMY 71.44
- Support Level
- SHO $8.95
- HRMY $32.77
- Resistance Level
- SHO $9.39
- HRMY $34.80
- Average True Range (ATR)
- SHO 0.29
- HRMY 1.20
- MACD
- SHO -0.01
- HRMY 0.22
- Stochastic Oscillator
- SHO 45.31
- HRMY 80.55
About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.